Malaria study - bulaquine versus primaquine
Not Applicable
Completed
- Conditions
- Infections and Infestationsncomplicated P. falciparum malariaUncomplicated P. falciparum malaria
- Registration Number
- ISRCTN50134587
- Lead Sponsor
- Indian Council of Medical Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 93
Inclusion Criteria
1. Aged more than 16 years
2. Uncomplicated Plasmodium falciparum malaria
3. Gametocyte count more than 55 /ul within 72 hours of diagnosis, irrespective of asexual parasitemia
4. Willing to give written, informed consent
Exclusion Criteria
1. Pregnancy
2. Lactation
3. Allergy to primaquine or bulaquine
4. Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency
5. Co-infection with Plasmodium vivax
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Gametocytemia at days 8, 15, 22 and 29 of follow-up
- Secondary Outcome Measures
Name Time Method Gametocyte viability at days 8, 15, 22 and 29